PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hematological oncology 2020-10, Vol.38 (4), p.618-621
Hauptverfasser:	Lou, Yinjun, Lu, Ying, Ye, Xingnong, Wang, Yungui, Ma, Yafang, Fan, Cuihua, Jiang, Huifang, Jin, Jie
Format:	Artikel
Sprache:	eng
Schlagworte:	acute promyelocytic leukemia Acute promyeloid leukemia Chemotherapy Leukemia minimal residual disease PML‐RARA Promyeloid leukemia Realgar‐Indigo naturalis formula
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	621
container_issue	4
container_start_page	618
container_title	Hematological oncology
container_volume	38
creator	Lou, Yinjun Lu, Ying Ye, Xingnong Wang, Yungui Ma, Yafang Fan, Cuihua Jiang, Huifang Jin, Jie
description
doi_str_mv	10.1002/hon.2766
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2419098414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2419098414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2416-c960f85f0d5be6e7c97207d6a3cbe74f85c08926fa5f541550808d75bf474ef83</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi0EEktB4hEsceGSMk7iOOG2qoAiLbSq4Bx5nXHj4tjBdrTkxiP0VXglngQvrYSE1NMc5pt_Pukn5CWDUwZQvhm9Oy1F0zwiGwZdVzBousdkA6VoCyir8il5FuMNQN5BuyG_Lj_tfv-8vdpebenknUk-GHdNjaMOD3alg5HXzkccqFRLQjoHP61ovVqTUdTi8g0nI2kKKFOGDiaNVDqKLpmA-d4HaakacfJpxCDnNT_TAXOQj_loMjEa76icc7BU41uaNRabzGwxS8Rk0pKOAP6YMRh0Cp-TJ1raiC_u5wn5-v7dl7PzYnfx4ePZdleosmZNoboGdMs1DHyPDQrViRLE0MhK7VHUeaWg7cpGS655zTiHFtpB8L2uRY26rU7I67vcbPZ9wZj6LKvQWunQL7HPXzro2prVGX31H3rjl-CyXaZ4xeqSV-JfoAo-xoC6n4OZZFh7Bv2xuz531x-7y2hxhx6MxfVBrj-_-PyX_wOOwKD4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2453142537</pqid></control><display><type>article</type><title>PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lou, Yinjun ; Lu, Ying ; Ye, Xingnong ; Wang, Yungui ; Ma, Yafang ; Fan, Cuihua ; Jiang, Huifang ; Jin, Jie</creator><creatorcontrib>Lou, Yinjun ; Lu, Ying ; Ye, Xingnong ; Wang, Yungui ; Ma, Yafang ; Fan, Cuihua ; Jiang, Huifang ; Jin, Jie</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.2766</identifier><language>eng</language><publisher>Chichester, UK: John Wiley & Sons, Inc</publisher><subject>acute promyelocytic leukemia ; Acute promyeloid leukemia ; Chemotherapy ; Leukemia ; minimal residual disease ; PML‐RARA ; Promyeloid leukemia ; Realgar‐Indigo naturalis formula</subject><ispartof>Hematological oncology, 2020-10, Vol.38 (4), p.618-621</ispartof><rights>2020 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2416-c960f85f0d5be6e7c97207d6a3cbe74f85c08926fa5f541550808d75bf474ef83</citedby><cites>FETCH-LOGICAL-c2416-c960f85f0d5be6e7c97207d6a3cbe74f85c08926fa5f541550808d75bf474ef83</cites><orcidid>0000-0002-2657-6716 ; 0000-0003-4495-2460</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.2766$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.2766$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids></links><search><creatorcontrib>Lou, Yinjun</creatorcontrib><creatorcontrib>Lu, Ying</creatorcontrib><creatorcontrib>Ye, Xingnong</creatorcontrib><creatorcontrib>Wang, Yungui</creatorcontrib><creatorcontrib>Ma, Yafang</creatorcontrib><creatorcontrib>Fan, Cuihua</creatorcontrib><creatorcontrib>Jiang, Huifang</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><title>PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience</title><title>Hematological oncology</title><subject>acute promyelocytic leukemia</subject><subject>Acute promyeloid leukemia</subject><subject>Chemotherapy</subject><subject>Leukemia</subject><subject>minimal residual disease</subject><subject>PML‐RARA</subject><subject>Promyeloid leukemia</subject><subject>Realgar‐Indigo naturalis formula</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhi0EEktB4hEsceGSMk7iOOG2qoAiLbSq4Bx5nXHj4tjBdrTkxiP0VXglngQvrYSE1NMc5pt_Pukn5CWDUwZQvhm9Oy1F0zwiGwZdVzBousdkA6VoCyir8il5FuMNQN5BuyG_Lj_tfv-8vdpebenknUk-GHdNjaMOD3alg5HXzkccqFRLQjoHP61ovVqTUdTi8g0nI2kKKFOGDiaNVDqKLpmA-d4HaakacfJpxCDnNT_TAXOQj_loMjEa76icc7BU41uaNRabzGwxS8Rk0pKOAP6YMRh0Cp-TJ1raiC_u5wn5-v7dl7PzYnfx4ePZdleosmZNoboGdMs1DHyPDQrViRLE0MhK7VHUeaWg7cpGS655zTiHFtpB8L2uRY26rU7I67vcbPZ9wZj6LKvQWunQL7HPXzro2prVGX31H3rjl-CyXaZ4xeqSV-JfoAo-xoC6n4OZZFh7Bv2xuz531x-7y2hxhx6MxfVBrj-_-PyX_wOOwKD4</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Lou, Yinjun</creator><creator>Lu, Ying</creator><creator>Ye, Xingnong</creator><creator>Wang, Yungui</creator><creator>Ma, Yafang</creator><creator>Fan, Cuihua</creator><creator>Jiang, Huifang</creator><creator>Jin, Jie</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2657-6716</orcidid><orcidid>https://orcid.org/0000-0003-4495-2460</orcidid></search><sort><creationdate>202010</creationdate><title>PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience</title><author>Lou, Yinjun ; Lu, Ying ; Ye, Xingnong ; Wang, Yungui ; Ma, Yafang ; Fan, Cuihua ; Jiang, Huifang ; Jin, Jie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2416-c960f85f0d5be6e7c97207d6a3cbe74f85c08926fa5f541550808d75bf474ef83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>acute promyelocytic leukemia</topic><topic>Acute promyeloid leukemia</topic><topic>Chemotherapy</topic><topic>Leukemia</topic><topic>minimal residual disease</topic><topic>PML‐RARA</topic><topic>Promyeloid leukemia</topic><topic>Realgar‐Indigo naturalis formula</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lou, Yinjun</creatorcontrib><creatorcontrib>Lu, Ying</creatorcontrib><creatorcontrib>Ye, Xingnong</creatorcontrib><creatorcontrib>Wang, Yungui</creatorcontrib><creatorcontrib>Ma, Yafang</creatorcontrib><creatorcontrib>Fan, Cuihua</creatorcontrib><creatorcontrib>Jiang, Huifang</creatorcontrib><creatorcontrib>Jin, Jie</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lou, Yinjun</au><au>Lu, Ying</au><au>Ye, Xingnong</au><au>Wang, Yungui</au><au>Ma, Yafang</au><au>Fan, Cuihua</au><au>Jiang, Huifang</au><au>Jin, Jie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience</atitle><jtitle>Hematological oncology</jtitle><date>2020-10</date><risdate>2020</risdate><volume>38</volume><issue>4</issue><spage>618</spage><epage>621</epage><pages>618-621</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester, UK</cop><pub>John Wiley & Sons, Inc</pub><doi>10.1002/hon.2766</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-2657-6716</orcidid><orcidid>https://orcid.org/0000-0003-4495-2460</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0278-0232
ispartof	Hematological oncology, 2020-10, Vol.38 (4), p.618-621
issn	0278-0232 1099-1069
language	eng
recordid	cdi_proquest_miscellaneous_2419098414
source	Wiley Online Library Journals Frontfile Complete
subjects	acute promyelocytic leukemia Acute promyeloid leukemia Chemotherapy Leukemia minimal residual disease PML‐RARA Promyeloid leukemia Realgar‐Indigo naturalis formula
title	PML‐RARA monitoring in newly diagnosed acute promyelocytic leukemia treated with an entirely oral chemotherapy‐free postremission approach: A multiple institution experience
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T21%3A53%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PML%E2%80%90RARA%20monitoring%20in%20newly%20diagnosed%20acute%20promyelocytic%20leukemia%20treated%20with%20an%20entirely%20oral%20chemotherapy%E2%80%90free%20postremission%20approach:%20A%20multiple%20institution%20experience&rft.jtitle=Hematological%20oncology&rft.au=Lou,%20Yinjun&rft.date=2020-10&rft.volume=38&rft.issue=4&rft.spage=618&rft.epage=621&rft.pages=618-621&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.2766&rft_dat=%3Cproquest_cross%3E2419098414%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2453142537&rft_id=info:pmid/&rfr_iscdi=true